Navigation Links
Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch
Date:7/24/2008

ST. LOUIS, July 24 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) announced today that it has received regulatory approvals for Roundup Ready 2 Yield(TM) soybeans in Mexico, Australia and New Zealand. In addition, the company noted the European Food Safety Authority (EFSA) has issued a positive scientific opinion concluding Roundup Ready 2 Yield is safe for import as food or feed. Roundup Ready 2 Yield soybeans are the second generation of the popular Roundup Ready(R) technology in soybeans and offer increased yields.

"These regulatory decisions by Mexico and Europe represent significant steps forward in delivering Roundup Ready 2 Yield soybeans to our customers," according to Brett Begemann, Monsanto's executive vice president of global commercial business. "Farmers have used Roundup Ready(R) soybeans for more than 10 years to achieve unsurpassed weed control. Roundup Ready 2 Yield soybeans have increased yields, and will advance farmers' ability to meet the world's growing food, feed and fuel needs."

Roundup Ready 2 Yield soybeans have now been approved in the United States, Canada, Mexico, Taiwan, Japan, the Philippines, Australia and New Zealand, says Jerry Hjelle, Monsanto's regulatory vice president.

"These recent approvals add to the list of countries that have reviewed and concluded that Roundup Ready 2 Yield soybeans are safe," he explains. "The positive EFSA opinion on safety is an important step toward gaining approval within the European Union. Moreover, we are working diligently to achieve regulatory clearance in other markets in anticipation of a 2009 release."

In four years of testing, Roundup Ready 2 Yield soybeans have demonstrated a consistent yield advantage of 7 percent to 11 percent when compared with its predecessor, Roundup Ready soybeans. The four-year average yield increase of Roundup Ready 2 Yield over its first-generation counterpart was 9 percent.

Monsanto's Roundup Ready 2 Yield soybeans will be introduced on 1 million to 2 million acres for the 2009 season as part of a controlled commercial release, followed by a large-scale product launch of 5 million to 6 million acres scheduled for 2010.

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see: http://www.monsanto.com.

Note to editors: Roundup Ready 2 Yield is a trademark of Monsanto Company and its wholly owned subsidiaries.


'/>"/>
SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
2. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
3. Monsanto Executives to Address Investor Conferences in February
4. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
5. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
6. Monsanto and Devgen Describe New Approach to Insect-Protection
7. Monsanto Company Executives Adopt 10b5-1 Trading Plans
8. Science Magazine Recognizes Monsanto as Top Employer
9. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
10. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
11. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... ... market news outlet had provided a research update on Aytu Bioscience and cited ... product. , According to Soulstring, prescription rates for Natesto® have more than doubled ...
(Date:8/16/2017)... ... 16, 2017 , ... Tunnell Consulting announced today that four of ... Annual Meeting and Expo , to be held October 29 through November 1 in ... innovation to advance patient therapies.” , The ISPE Annual Meeting and Expo will feature ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... a different cell type. Many treatments for specific cancers, such as breast, prostate, ... targeted treatment is androgen deprivation therapy for advanced prostate cancer. , This ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... beneficial microbe delivery system, announced it has secured $2M in funding from an ... City Angels, Carmen Innovations, and SVG Thrive Fund. With this investment, 3Bar is ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
Breaking Biology News(10 mins):